Linked Life Data

6487893

Source:http://linkedlifedata.com/resource/pubmed/id/6487893

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6487893rdf:typepubmed:Citationlld:pubmed
pubmed-article:6487893lifeskim:mentionsumls-concept:C0007450lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C0008010lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C0007277lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C0022616lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:6487893lifeskim:mentionsumls-concept:C0065809lld:lifeskim
pubmed-article:6487893pubmed:issue1lld:pubmed
pubmed-article:6487893pubmed:dateCreated1984-11-28lld:pubmed
pubmed-article:6487893pubmed:abstractTextThe effects of intracarotid (i.c.) injections of 5-hydroxytryptamine (5-HT; 1-50 micrograms) on carotid chemoreceptor activity recorded from the carotid sinus nerve have been studied in anaesthetized cats. Three separate components in the complex response of the chemoreceptors to injected 5-HT were identified. Firstly, a transient burst of activity was obtained during the injection period in 56% of the recordings. Secondly, in all the recordings a period of chemodepression commenced a few seconds after completing the injection and was usually dose-related. Thirdly, a delayed longer-lasting chemoexcitation occurred in many experiments, concomitant with a fall in systemic blood pressure. The neuronal 5-HT receptor antagonist MDL 72222 (10-100 micrograms kg-1, i.c.) virtually abolished the transient chemoexcitation evoked during 5-HT injections and also significantly increased the mean ID50 for 5-HT-induced chemodepression; in 37% of recordings 5-HT caused a dose-related chemoexcitation after the high dose of MDL 72222. Neither the delayed chemoexcitation nor the hypotension caused by 5-HT were much affected by the antagonist. MDL 72222 itself had a biphasic effect on chemosensory discharge, causing depression followed by a delayed excitation. The 5-HT2-receptor antagonist ketanserin (100 micrograms kg-1, i.c.) had no appreciable effect on the transient chemoexcitation evoked during 5-HT injections and caused a slight but significant increase in the mean ID50 for 5-HT-induced chemodepression. The delayed chemoexcitation and accompanying hypotension associated with 5-HT were both substantially reduced or abolished by the antagonist. Ketanserin itself caused a short-lasting period of chemoexcitation. All the effects of injected 5-HT on chemosensory discharge could be abolished by the combination of MDL 72222 and ketanserin (100 micrograms kg-1, i.c.). Neither MDL 72222 nor ketanserin had any significant effect upon the response of the carotid chemoreceptors to hypoxia. The rate at which discharge increased, and also the steady-state discharge before and during hypoxia, were unaffected by the antagonists, alone or in combination. At least two types of 5-HT receptor appeared to be involved in the response of carotid body chemoreceptors to 5-HT. Transient excitation and chemodepression were mediated via MDL 72222-sensitive (peripheral neuronal) receptors whereas the delayed chemoexcitation and associated hypotension involved a ketanserin-sensitive, presumably 5-HT2-, receptor. It appears unlikely that 5-HT plays a crucial role in chemoreception.lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:languageenglld:pubmed
pubmed-article:6487893pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:citationSubsetIMlld:pubmed
pubmed-article:6487893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6487893pubmed:statusMEDLINElld:pubmed
pubmed-article:6487893pubmed:monthSeplld:pubmed
pubmed-article:6487893pubmed:issn0007-1188lld:pubmed
pubmed-article:6487893pubmed:authorpubmed-author:KirbyG CGClld:pubmed
pubmed-article:6487893pubmed:authorpubmed-author:McQueenD SDSlld:pubmed
pubmed-article:6487893pubmed:issnTypePrintlld:pubmed
pubmed-article:6487893pubmed:volume83lld:pubmed
pubmed-article:6487893pubmed:ownerNLMlld:pubmed
pubmed-article:6487893pubmed:authorsCompleteYlld:pubmed
pubmed-article:6487893pubmed:pagination259-69lld:pubmed
pubmed-article:6487893pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:meshHeadingpubmed-meshheading:6487893-...lld:pubmed
pubmed-article:6487893pubmed:year1984lld:pubmed
pubmed-article:6487893pubmed:articleTitleEffects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine.lld:pubmed
pubmed-article:6487893pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6487893pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6487893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6487893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6487893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6487893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6487893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6487893lld:pubmed